den vaccine f17
Vaccineexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2005 (NCT01843621)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Dengue virusImmunity, active
Dengue virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- den vaccine f17
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01843621 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2005 | Department of Defense, GlaxoSmithKline, Government of Thailand, United States Army |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Department of Defense | Government | 1 | 0 | 1 | 2005 |
| GlaxoSmithKline | For profit | 1 | 0 | 1 | 2005 |
| Government of Thailand | Government | 1 | 0 | 1 | 2005 |
| United States Army | Government | 1 | 1 | 1 | 2005 |
4 organizations
Page 1 / 1